During cutaneous wound healing, a marked increase in the local expression of growth factors results in increased migration and proliferation of the cells responsible for tissue repair. The mitogenregulated protein (MRP)/proliferin proteins are growth factors and angiogenesis factors. Here it is demonstrated that Mrp3 is induced in wound edge keratinocytes during cutaneous wound healing and also temporally appears in the outer root sheath of the hair follicle during the late anagen phase of the hair cycle. In cultured keratinocytes, Mrp3 is induced by keratinocyte growth factor, but not by epidermal growth factor or by transforming growth factor type ␣. Transgenic mice, expressing lacZ under the combined control of the cytomegalovirus immediate early enhancer and the Mrp3 flanking sequences, demonstrate wound-and hair cycle-induced transgene expression. These results show that elements within the flanking regulatory sequences of the Mrp3 gene are involved in the activation of Mrp3 in response to these events. The results reported here suggest that MRP3 may participate in wound healing and hair follicle cycle as a growth factor and/or angiogenesis factor. (Endocrinology 142: 2129 -2137, 2001) 
growth factor or by transforming growth factor type ␣. Transgenic mice, expressing lacZ under the combined control of the cytomegalovirus immediate early enhancer and the Mrp3 flanking sequences, demonstrate wound-and hair cycle-induced transgene expression. These results show that elements within the flanking regulatory sequences of the Mrp3 gene are involved in the activation of Mrp3 in response to these events. The results reported here suggest that MRP3 may participate in wound healing and hair follicle cycle as a growth factor and/or angiogenesis factor. (Endocrinology 142: 2129 -2137, 2001) A HALLMARK OF wound healing is the release of growth factors at levels much higher than are typically found in nonwounded skin (1) . Fibroblast growth factor (FGF) family members stimulate angiogenesis (2) as well as migration and proliferation of fibroblasts and keratinocytes (3, 4) . Expression of a dominant negative FGF7 receptor in the skin of mice delays wound healing (5) . The application of basic FGF (bFGF) enhances wound healing in healingimpaired db/db mice (6) . Thus, reepithelialization and tissue repair are probably mediated in part by the ability of skin cells to appropriately respond to FGFs and other growth factor signals.
Growth factors, including FGF5, FGF7, epidermal growth factor (EGF), and transforming growth factor-␣ (TGF␣) are also involved in hair follicle morphogenesis, as evidenced by the hair-associated abnormalities linked to mutations or introduced knockouts of these genes or their receptors (7, 8) . The hair follicle contains stem cells that probably contribute to cutaneous wound healing by providing a source of the keratinocytes that migrate and proliferate to repair the wound (9) .
The mitogen-regulated protein/proliferins (MRP/PLFs) are a group of highly homologous, well characterized, growth factor-inducible secondary response genes and members of the PRL/GH family. In immortalized mesenchymal cells derived from mouse embryos (3T3 cells), Mrp/Plf expression is increased in response to bFGF and other growth factors (10) . Expression of Mrp/Plf is greater in growing than in quiescent cells (11) . This may be explained in part by the fact that TGF␤ inhibits Mrp/Plf expression in quiescent, but not in growing, cells (12) .
There are between four and six Mrp/Plf genes (13) , and the four cloned complementary DNAs (cDNAs; Plf1, Plf2, Mrp3, and Mrp4) are highly identical to one another (14, 15) . Although some nonplacental cell lines express Mrp/Plfs in vitro, the only tissue identified in the mouse in which Mrp/Plf expression was identified until recently is the placenta (16) . Mrp/Plf expression is localized to the trophoblastic giant cells, which secrete high levels of MRP/PLFs during midgestation (17, 18) . Placental MRP/PLFs are believed to be angiogenesis factors in the fetal placenta. PLF1 stimulates angiogenesis by interacting with the mannose 6-phosphate receptor (19) . It is also a growth factor for uterine cells acting through a separate receptor in the uterus that does not recognize mannose-6-phosphate (20, 21) . Thus, the MRP/PLFs are believed to coordinate aspects of fetal and maternal development during pregnancy through their ability to regulate cell proliferation and angiogenesis.
Because growth factors are expressed at high levels during wound healing, and the Mrp/Plfs are highly up-regulated by growth factors in 3T3 cells, we investigated the possibility that Mrp/Plf expression might also be increased during wound repair. Here we demonstrate that Mrp3 is expressed specifically in suprabasal keratinocytes at the wound site, and its expression is regulated temporally during cutaneous wound healing. MRP/PLF protein and RNA expression are also regulated during the hair follicle cycle, during which immunohistochemistry reveals the protein predominantly in the outer root sheath. The same distribution and regulation of expression were found in transgenic mice expressing a lacZ transgene under combined control of the cytomegalovirus immediate early (CMV-IE) enhancer and the Mrp3 flanking sequences. We also show that Mrp3 expression is induced by keratinocyte growth factor (KGF; FGF 7) in primary cultures of keratinocytes. These data suggest that MRP3 plays a role during cutaneous wound repair and in the hair follicle cycle. A likely regulator of Mrp3 gene expression in the skin is KGF.
Materials and Methods

Animals and materials
CF-1 and FVB mice, originally obtained from Charles River Laboratories, Inc. (Wilmington, MA), were bred and cared for at the Laboratory Animal Facility at Iowa State University under a 12-h light, 12-h dark cycle. All animals were housed and treated according to current NIH guidelines. Care was provided by an animal caretaker and an attending veterinarian. With the exception of removal of tail segments, animals were killed by CO 2 asphyxiation before removal of tissues for the described studies. This research was conducted in accordance with the standards set forth in the NIH Guide for the Care and Use of Laboratory Animals. Prior approval was obtained from the Iowa State University committee on animal care for all procedures performed on the animals used in these studies.
Polyclonal anti-MRP/PLF rabbit serum and preimmune serum were prepared as described previously (22) . Plasmid vector pckt17-2, a modified pSP73 (Promega Corp., Madison, WI), was a gift from Christopher Tuggle (Iowa State University). KGF was purchased from R&D Systems, Inc. (Minneapolis, MN).
Wound healing experiments
FVB mice (Charles River Laboratories, Inc.) were used for most wound healing experiments, except for experiments performed on transgenic animals, which were either FVB or FVB/CF-1 crosses. To produce wounds, adult mice were anesthetized using Avertin, prepared as previously described (23) , and scissors were used to make 0.5-to 1-cm full thickness skin wounds laterally along the back. Two equally spaced nylon sutures (5-0 ethilon, Ethicon, Somerville, NJ) were used to close each 1-cm wound in the back. In some cases the tip of the tail was cut off to produce a wound and for use in identifying transgenic offspring. At various times after wounding, the wound tissue was removed and either fixed for immunohistochemistry or frozen in liquid nitrogen and stored at Ϫ70 C until used for RNA isolation.
Depilation experiments
For depilation experiments, adult mice C57/BL6ϫCF-1 (6 -8 weeks) were anesthetized with Avertin, and the hair was removed using a mixture of bees wax and rosin (ZIP, Lee Pharmaceuticals, South El Monte, CA). The day of depilation was designated day 0. On the specified days after depilation, mice were killed, and each sample of depilated skin was cut in half for analysis by immunohistochemistry and RT-PCR, respectively. The stage of hair follicle growth was established by the morphology of the hair follicles (24) .
Immunohistochemistry
Animals were killed on days 0 -10 after wounding or days 2.5-17.5 after depilation. Tissues were immediately fixed in 4% paraformaldehyde in PBS (0.14 m NaCl, 2.7 mm KCl, 4 mm Na 2 HPO 4 , and 14.7 mm KH 2 PO 4 , pH 7.4) for 1-2 h at 4 C. Samples were then rinsed in PBS and stored in 70% ethanol until sectioned. For immunodetection of MRP/ PLFs, 6-m sections were rehydrated and stained as previously described (25) using a polyclonal rabbit anti-MRP/PLF serum (89rb13a) or a preimmune serum from the same animal, each at a dilution of 1:500. Primary antibody was detected using biotinylated goat antirabbit IgG and horseradish peroxidase conjugated to avidin and was visualized by a peroxidase substrate, diaminobenzidine tetrahydrochloride (ABC kit, Vectastain, Vector Laboratories, Inc., Burlingame, CA). Samples were counterstained with hematoxylin and eosin, dehydrated, and mounted with Permount (Fisher Scientific, Pittsburgh, PA) with a coverslip on top.
RNA isolation, RT-PCR, and diagnostic RT-PCR
Frozen tissue was pulverized in liquid nitrogen using a mortar and pestle, and total RNA was isolated by using Tri-Reagent (Life Technologies, Inc., Gaithersburg, MD) according to the manufacturer's instructions. RT and RT-PCR were performed as previously described (15, 21) . For PCR of Mrp/Plf cDNAs, the following primers were used: DE1; 5Ј-taagcctgggtaggactctgca-3Ј (ϩ42 to ϩ63); and UEV, 5Ј-catgatatttcagaagcagagcac-3Ј (ϩ776 to ϩ754). For G3pdh, the primers used were 5Ј-tgtggatggcccctctggaaa-3Ј (ϩ601 to ϩ621) for the upstream primer and 5Ј-gtttcttactccttggaggc-3Ј (ϩ1053 to ϩ1034) for the downstream primer.
The diagnostic RT-PCR assay for the Mrp/Plfs is based on minor differences in the cDNA sequences of these closely related gene products that result in the presence or absence of restriction sites within the cDNA (15, 21) . Amplified, radiolabeled fragments were digested with 1 U each of BsoFI and BstXI (New England Biolabs, Inc., Beverly, MA) at 55 C overnight in 50 mm NaCl, 10 mm MgCl 2 , 1 mm dithiothreitol, 100 g/ml BSA, 10 mm Tris-HCl (pH 7.9 at 22 C). The radiolabeled and digested products were resolved by electrophoresis through 10% nondenaturing polyacrylamide gels. The gels were dried and exposed to film. Positive controls for identification of specific Mrp/Plfs were Plf1, Plf2, Mrp3, and Mrp4 cDNAs.
Keratinocyte isolation and culture
Newborn mouse keratinocytes were isolated as previously described (26) with some minor modifications. Briefly, newborn (days 3-4) mouse skin was removed and incubated overnight in 0.25% trypsin in HBSS without Ca 2ϩ or Mg 2ϩ (Life Technologies, Inc.). Epidermis was separated from dermis with tweezers, and then the dermis was gently scraped with a razor blade to remove any keratinocytes that remained with the epidermis. Epidermis was finely minced in Vogt's DMEM with high glucose (Life Technologies, Inc.) containing 10% calf serum. Larger pieces were removed with tweezers. The cells were collected by centrifugation at 500ϫ g for 10 min, washed in HBSS, and resuspended in serum-free keratinocyte medium (Life Technologies, Inc.) containing 25 g/ml bovine pituitary extract (Life Technologies, Inc.), 2.5 ng/ml recombinant EGF (Life Technologies, Inc.), 100 U/ml penicillin/streptomycin, and 90 m CaCl 2 . After being cultured overnight, unattached cells were removed, and the medium was replaced with fresh medium as before, but with 75 m CaCl 2 . Keratinocytes were cultured for up to 4 days with daily medium changes, and then the cells were cultured for an additional 2 days without changing the medium. The medium was removed, and fresh serum-free medium was added without pituitary extract, but with the indicated growth factors. Total RNA was isolated after an additional 14 -17 h of culture.
Transgenic mice
Transgenic mice were produced by microinjection of a linearized construct as described previously (27) . The full-length construct (CMV/ Mrp3/sisGal/3U) contains the following elements in order of 5Ј to 3Ј: a 307-bp NruI-BanI fragment containing the CMV-IE enhancer from pcDNA-3 (Invitrogen, San Diego, CA), a 1514-bp XbaI to PstI fragment of the Mrp3 promoter (Ϫ1450 to ϩ64), the adenovirus/IgG hybrid intron (28), the lacZ gene, and a PvuII/EcoRI fragment including part of exon 5 of the Mrp3 gene to the 3Ј-polyadenylase site (170 bp) and about 600 bp 3Ј to the PvuII/EcoRI fragment in the Mrp3 gene. As well, the fulllength construct contained the adjacent approximately 3000-bp EcoRI fragment that is 3Ј to the PvuII/EcoRI 3Ј-end of the Mrp3 gene. Partial constructs were also used to prepare transgenic animals. These partial constructs consisted of the same portions of the transgene just described, but were lacking either the 3-kb EcoRI fragment of the Mrp3 gene or the 5Ј Mrp3 sequence from Ϫ42 to Ϫ1450 of the Mrp3 promoter had approximately 600 bp instead of approximately 3 kb of the 3Ј Mrp3 untranslated region. To prepare the construct for microinjection, the DNA was digested by NotI to remove it from the vector (pckt17-2), resolved by electrophoresis through a 0.8% agarose gel, and purified with GeneClean 101 (Bio 101, La Jolla, CA). The eluted DNA was precipitated with ethanol, washed twice in 70% ethanol, and resuspended in 150 m EDTA and 10 mm Tris-HCl, pH 7.4. Transgenic mice were identified by PCR analysis of DNA isolated from tail or ear tissue. ␤-Galactosidase activity in wounds or hair follicles was detected as follows. Tissues were fixed for 40 min in 4% paraformaldehyde in PBS, then washed three times in PBS containing 0.01% Tween 20 and 0.02% sodium deoxycholate. The tissue was stained overnight at 30 C in 0.01% Tween 20, 0.02% sodium deoxycholate, 5 mm potassium ferricyanide, 5 mm potassium ferrocyanide, 2 mm MgCl 2 , 1 mg/ml X-gal, and 0.1 m sodium phosphate, pH 7.4.
Results
MRP/PLF proteins are present in keratinocytes of regenerating epidermis
To determine whether the MRP/PLFs are produced during wound healing, full thickness wounds were created on the backs of mice, and at various times after wounding, immunohistochemistry was performed on the wounded skin tissue using anti-MRP/PLF. Each mouse was given a single wound. Antibody staining was most evident over the suprabasal keratinocytes at the wound edge between days 4 and 5 after wounding (Fig. 1, top panel) . Thirteen of the 15 wounds examined between days 4 and 5.5 showed staining in the wound area as in Fig. 1 . Staining was never found in nonwounded tissue (n ϭ 8) or in wounds of 1 day (n ϭ 2) or 2.5 days (n ϭ 2). One in three wounds examined on day 3 were stained over the keratinocytes. MRP/PLF staining is coincident with the period of hyperproliferation of wound edge keratinocytes that occurs on about day 4. MRP/PLF staining was also less intense as the wound became reepithelialized after day 7.5 (n ϭ 6; data not shown). Basal keratinocytes were not stained. Stain was occasionally found over the outermost terminally differentiated keratinocytes. Often, keratinocytes that stained for the MRP/PLFs were located along the hair follicles near the wound. There was no stain using preimmune sera (Fig. 1, middle panel) . None of the 19 wounds showed staining over keratinocytes in areas removed from the wound as shown for the wound in Fig 1  (bottom panel) .
Staining was occasionally detected in the outer root sheath of hair follicles not associated with the wound, and staining over these follicles was independent of the stage of wound healing (data not shown). These hair follicles appeared to be in the anagen stage of the hair cycle, during part of which, as we show later in this report, the Mrp3 gene is expressed in the outer root sheath.
Mrp3 is the major Mrp/Plf gene expressed during wound healing
The presence of MRP/PLF protein in the suprabasal keratinocytes suggested that one or more of the Mrp/Plf genes were turned on in wounded tissue. Total RNA was extracted from wounds at different times after wound healing and subjected to RT-PCR. G3pdh was also amplified from the same cDNAs in parallel analyses to serve as controls for sample quality. Mrp/Plf messenger RNA (mRNA) was detected in wound tissue after 1 day of wounding and seemed to be present at the highest levels at 2.5 days after wounding ( Fig. 2A) .
To determine which Mrp/Plfs are expressed during wound healing, the four known Mrp/Plf gene products were distinguished by diagnostic RT-PCR as described in Materials and Methods. A portion of each sample shown in Fig. 2A was amplified for an additional single round in the presence of ␣[
32 P]deoxy-CTP, digested with Bsof1 and Bstx1, and separated on a nondenaturing 10% polyacrylamide gel. Standards for individual Mrp/Plf forms were treated similarly and used as controls for the expected fragments. As shown in Fig. 2B for day 2.5, Mrp3 makes up most of the Mrp/Plf mRNA found in skin wounds. Similar results were found for each day for which RNA could be detected by RT-PCR.
Keratinocyte regulation of Mrp/Plf expression in response to growth factors
To better understand which growth factors may be inducing Mrp/Plf expression at the wound edge, newborn mouse keratinocytes were isolated and treated with KGF (FGF7), EGF, or TGF␣. Mrp/Plf gene expression, as measured by Northern blot analysis, was increased in response to KGF, whereas EGF and TGF␣ had no effect on the level of Mrp/Plf mRNA (Fig. 3, A and B) . As in the wound, Mrp3 was the major form of Mrp/Plf expressed by FGF-stimulated mouse keratinocytes, although some Plf1 was also expressed (Fig.  3C ). By comparison, 3T3 cells expressed mostly Plf1.
Mrp3 transgene expression in response to wound healing
Transgenic mice carrying the CMV/MRP3/lacZ/3U DNA construct were examined for ␤-galactosidase expression in response to wound healing. In full thickness cutaneous wounds in the back, staining was evident between 1 and 5 days after injury in one of two independently isolated transgenic lines containing the complete CMV/Mrp3 construct ( Fig. 4A ) and in two independent transgenic mouse lines containing a CMV/MRP3/lacZ construct that contained about 600 bp instead of about 3 kb of 3Ј Mrp3 untranslated region. One of the latter two lines also showed staining in the panniculous carnosis. Both the location and the time course of transgene expression were similar to those of endogenous Mrp3 expression.
In all four transgenic lines containing the CMV/MRP3/ lacZ construct with approximately 600 bp or approximately 3Ј 3 kb of the Mrp3 sequence, tail injury resulted in expression of lacZ specifically in the skin around the edge of the wound (Fig. 4B) . No staining was observed in tissue fixed immediately after wounding (Fig. 4C) . In a control transgenic mouse line containing the CMV-IE enhancer but only 42 bp of the Mrp3 promoter, lacZ was expressed constitutively throughout the skin and in most other organs tested as well (not shown).
Presence of MRP/PLFs in the hair follicle
In the course of these studies it was noticed that some hair follicles also stained for MRP/PLFs. The protein was detected by immunocytochemistry using anti-MRP/PLF, but not with preimmune serum (Fig. 5, A and B) . MRP/PLF staining was strongest in the outer root sheath of the hair follicle and was absent from the bulb. The morphology of the follicles that were stained with anti-MRP/PLF indicated that they were in the anagen stage of the hair follicle cycle. 
Regulation of Mrp/Plf genes during hair follicle morphogenesis
To analyze expression of the Mrp/Plf genes during the hair follicle cycle, black-coated C57/BL6ϫCF-1 hybrid mice were depilated, and skin samples were collected at various times thereafterward. Staining was evident in some follicles in the outer root sheath during midanagen (day 8) and was more extensive at late anagen (day 17.5) of the hair follicle cycle. No staining was evident when preimmune serum was used (Fig. 5 , A, C, E, and H). Staining was also seen in the outermost epidermal layers.
RNA isolated from nearby skin of the same animals was analyzed by diagnostic RT-PCR (Fig. 6) . Expression of Mrp/ Plfs was highest by day 17.5 ( Fig. 6A) , which corresponds to late anagen (29) . Mrp3 was the predominantly expressed Mrp/Plf during normal hair follicle cycling (Fig. 6B) . Smaller proportions of Plf1 and Mrp4 were also expressed.
The CMV/MRP3/lacZ/3U transgenic mice showed strong ␤-galactosidase staining in the outer root sheath of anagen hair follicles (Fig. 7A) . Staining in the more external elements of the hair follicles was generally darker and more consistent than staining near the bulb region. This could have been due to limitations in the penetration of the X-gal through the tissues. Consequently, the distribution of ␤-galactosidase expression was also determined in hair follicles that had been plucked from the animal before staining (Fig. 7B) .
Discussion
For many years, the only reported in vivo sites of Mrp/Plf expression were the trophoblastic giant cells of the placenta (17) . Recently, we demonstrated the selective expression of Mrp4 in the hair follicles of the tail (15) Here we show that another member of this family, Mrp3, is selectively expressed 
FIG. 4. The
Mrp3 promoter directs appropriate expression of lacZ in healing wounds. Three or 4 days after wounding, the expression of the CMV/Mrp3/lacZ/3u transgene was detected in cutaneous wounds in the back (A) or in tail wounds (B and C). Shown is a 4-day-old back wound of about 1 cm in length (A), a 3-day-old tail wound (B), and a second more proximal cut in the same tail as that in B, but which was fixed immediately after wounding (C). Arrows point to locations of blue stain that indicate ␤-galactosidase activity and transgene expression.
in keratinocytes during wound healing and in the late anagen hair follicle.
Mrp3 gene expression starts soon after wounding, although the MRP3 protein is not detected by immunohistochemistry until it has accumulated to high levels 4 -5 days after wounding. The increase in Mrp3 gene expression revealed by RT-PCR begins early in the inflammatory stage and continues through the granulation stage of wound healing, the latter being the period of keratinocyte proliferation and the reepithelialization phase of wound healing (2) .
KGF, a potent keratinocyte mitogen (4), increases Mrp3 expression in keratinocytes in culture. In vivo, dominant negative KGF receptors cause severe defects in wound healing (30) , whereas KGF ligand knockouts show normal wound healing, but have abnormal coats (8) . These results suggest that signaling through KGF receptors is crucial for wound healing, but the KGF ligand itself is not essential. This result is consistent with the observation that several members of the FGF family interact with Fgfr2, the KGF receptor. Neither EGF nor TGF␣ increased Mrp/Plf expression by keratinocytes, even though these are mitogens for keratinocytes and stimulate Mrp/Plf expression in 3T3 cells (10) . Here it is relevant that Plf1 is the major Mrp/Plf gene expressed in 3T3 cells and the predominantly expressed gene in keratinocytes is Mrp3. The Mrp3 promoter, but not the Plf1 promoter, is stimulated by FGF in 3T3 cells (31) .
MRP3 was not detected in keratinocytes found at the wound surface, which are believed to be migrating across the wound. In humans, the migrating keratinocytes display the highest level of immunostaining for the cleaved and activated form of TGF␤ (32) . Mrp/Plf expression by 3T3 cells is inhibited by TGF␤ (12) . The results presented here showing that 3T3 cells express mostly Plf1 suggest that these previous studies demonstrated that TGF␤ inhibits the expression of Plf1. In 3T3 cells stably transfected with 2 kb of the Mrp3 promoter upstream from a chloramphenicol acetyltransferase reporter gene, TGF␤ also inhibited the Mrp3 promoter activity (Mohideen, M. A. K., and M. Nilsen-Hamilton, unpublished observations). Thus, Mrp3 expression may be suppressed by TGF␤ in migrating keratinocytes.
Although cultured keratinocytes are not physiologically equivalent to wounded skin, the regulation of Mrp/Plfs in response to growth factors may be similar to that in vivo. KGF is highly expressed by the dermis from 24 h after wound healing through at least 7 days (1). Mrp3 is expressed over this same period in suprabasal keratinocytes at the wound margins. During wound healing, proliferation of the underlying basal layer results in a greatly thickened layer of suprabasal keratinocytes. Although mitotic figures are evident in the suprabasal layer, the majority of cell proliferation in the wound is in basal keratinocytes. MRP3 might be part of a positive feedback mechanism by which the suprabasal cells stimulate further proliferation of the cells in the underlying basal layer. This mechanism would parallel that of PLF1, a growth factor for primary uterine cells (20) . Because the mature forms of MRP3 and PLF1 are 99% identical, with a variation in only 2 of 195 amino acids, it is presumed that these proteins have the same functions. This assumption has not yet been verified.
PLF1 signals through two different receptor types: a unique MRP/PLF receptor (20) and the insulin-like growth factor II (IGF-II)/mannose-6-phosphate receptor (33, 34) . In sheep, IGF-II receptors are expressed in the germinal matrix, with peak expression during late anagen/early catagen, and in the dermal papilla, with peak expression during telogen (35) . If the IGF-II receptor is similarly expressed in the mouse, then the cells expressing these receptors are possible targets for the MRP/PLFs that are expressed in late anagen.
The FGF family stimulates proliferation and angiogenesis and is involved in cutaneous wound healing. Expression of a dominant negative FGF7 receptor in the skin of mice delays wound healing (5) , and the application of bFGF enhances wound healing in healing-impaired db/db mice (6) . Some FGFs are also produced in hair follicles; Fgf5 and Fgf7 mRNAs are present in the outer root sheath during anagen IV (7, 36) . mRNAs encoding several FGF receptors are also present in the hair follicle during anagen: Fgfr1 mRNA in the dermal papilla, Fgfr2 RNA in hair matrix cells near the dermal papilla, Fgfr3 mRNA in precuticle cells in the periphery of the hair bulb, and Fgfr4 RNA in cells in the periphery of the hair bulb and the inner and outer root sheath in the lower half of the follicle neck. These FGFs and their receptors are likely to be active after the period of follicle growth, because proliferative cells are found in the outer root sheath during catagen and telogen (37) . KGF is specific for Fgfr2 (38) , but Fgfr4 is expressed by the outer root sheath cells. Thus, it is possible that an FGF other than KGF stimulates Mrp/Plf expression in these cells.
Expression of Mrp/Plf in the skin was confined to the wound keratinocytes and epithelial cells of the outer root sheath cells of the hair follicle. In these cells, Mrp3 was the major form expressed. Mrp3 expression was also observed in skin containing hair follicles in late anagen, where Plf1 and Mrp4 were also found in relatively smaller amounts. The expression of small proportions of Plf1 and Mrp4 in hair follicles and not in healing skin could reflect the different mouse strains used in the wound healing (FVB) and hair cycle (C57/BL6ϫCF-1 crosses) studies. However, we did not observe differences in Mrp/Plf types expressed in placental tissues from CF-1 and BALB/c mice (15) . Recently, we also observed the expression of predominantly Plf1 in stomach (unpublished) and Plf1 and Mrp3 in small intestine (15) , whereas Mrp4 is constitutively expressed in skin of the adult tail (15) . Thus, mice seem to have evolved mechanisms to express different Mrp/Plf forms in different epithelial tissues.
Transgenic mice containing a CMV/MRP3/lacZ transgene expressed ␤-galactosidase in the wound and hair follicles in the same cellular locations and with the same time course as seen by RT-PCR for endogenous mRNA expression and by immunocytochemistry for MRP/PLF protein localization. In these studies the presence of the CMV-IE enhancer seemed to increase expression from the Mrp3 promoter. In other   FIG. 7 . The Mrp3 promoter directs expression of lacZ to the outer root sheath during the hair cycle. CMV/MRP3/lacZ/3U-transgenic mice were shaved, then depilated. The tissue was fixed, sectioned, and stained for ␤-galactosidase activity (A). Hair follicles were also plucked, fixed, and stained for ␤-galactosidase activity (B). Transgene expression appears in the same location, as the immunostain of endogenous MRP/PLFs was found in other tissues slices (A) and can be seen in similar locations in the plucked hair follicles (B). studies, the CMV-IE enhancer did not efficiently increase transgene expression in the skin from the CMV promoter (39) . However, the CMV-IE enhancer in combination with the chicken ␤-actin promoter drove ␤-galactosidase transgene expression strongly in many locations in the skin, with the highest expression observed in the sebaceous gland, epidermis, suprabasal and basal cells of the epidermis, and arrector pili muscle. Expression was not high in the outer root sheath. Thus, the promoter (CMV or ␤-actin), rather than the CMV-IE enhancer, determines the pattern of expression of the transgene (39) . We show here a different expression pattern of the Mrp3 promoter in combination with the CMV-IE enhancer than previously reported for CMV-IE enhanced with the CMV promoter or with the ␤-actin promoter. Although the presence of the CMV-IE enhancer increases the level of transgene expression from the Mrp3 promoter, the information necessary to determine spatial expression of Mrp3 in the wound and the hair follicle seems to be present in the 1514-bp proximal Mrp3 promoter. This transgenic construct also expressed specifically in the giant cells of the placenta during gestation, which is the major site of Mrp3 expression during development (Fassett, J. T., and M. NilsenHamilton, in preparation).
If the functions of MRP/PLFs in the skin are similar to those proposed for MRP/PLFs during reproduction, then MRP3 might promote proliferation by way of the MRP/PLF receptor (20) and angiogenesis through the IGF-II receptor/ mannose-6-phosphate (19) .
The timing of Mrp3 expression during the late anagen stage of the hair follicle cycle is not consistent with an immediate effect of this growth factor on angiogenesis, because the perifollicular capillary bed regresses after anagen (40) . However, although most cell division ceases in the hair follicle after anagen, there is some proliferation in the outer root sheath during telogen (37) . Thus, the immediate role of MRP3 might be to stimulate outer root sheath cell proliferation at a time when most cell proliferation in the hair follicle has ceased. However, a highly glycosylated and very stable protein such as MRP3, produced and secreted late in the hair follicle cycle, might be adsorbed to the proteins in the extracellular matrix and then released at a later time by proteolysis or another means. Perhaps MRP3 is released directly before the anagen phase of the subsequent hair cycle when it could act as an angiogenic factor as well as a growth factor for the newly forming hair follicle.
In conclusion, we have shown that Mrp3 is expressed in keratinocytes during wound healing and in the outer root sheath of the late anagen hair follicle. Members of the FGF family are the most likely positive regulators of Mrp3 gene expression in the skin, whereas TGF␤ may be a negative regulator. Studies with transgenic mice suggest that the DNA elements necessary to direct Mrp3 expression in the wound and in the hair follicle are present in the DNA sequences flanking the Mrp3-coding sequence. On the basis of the current findings, we propose that MRP3, previously identified only in the placenta, may play a role during wound healing and in the hair follicle cycle as a growth factor and an angiogenesis factor.
